Shelley Zieroth(@ShelleyZieroth) 's Twitter Profileg
Shelley Zieroth

@ShelleyZieroth

Prof #heartsuccess, Past Pres @CanHFSociety, AE @JCardFail, SPC Chair @SCC_CCS #CCCongress +CCS HF GL Co-chair, President @fmwcanada (she/her) RT my own 👠💃

ID:2978611196

linkhttps://www.linkedin.com/in/shelley-zieroth-146a84191 calendar_today13-01-2015 05:41:49

16,1K Tweets

9,0K Followers

3,4K Following

Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

⚠️Great review 👉 Restrictive cardiomyopathy
📍definition
📍diagnosis
📍therapies available only for cardiac amyloidosis and, for iron overload cardiomyopath

🆓📁 academic.oup.com/eurheartj/adva…

⚠️Great review 👉 Restrictive cardiomyopathy 📍definition 📍diagnosis 📍therapies available only for cardiac amyloidosis and, for iron overload cardiomyopath 🆓📁 academic.oup.com/eurheartj/adva…
account_circle
CCS(@SCC_CCS) 's Twitter Profile Photo

The app is available for download: qrco.de/bdQZuW. You'll need to log in the first time using your MY.CCS.ca credentials. Pro tip for in-person delegates: download the app today - you'll need it to print your badge at registration next week!

The #CCCongress app is available for download: qrco.de/bdQZuW. You'll need to log in the first time using your MY.CCS.ca credentials. Pro tip for in-person delegates: download the app today - you'll need it to print your badge at registration next week!
account_circle
Henry Han , MBBS, MD(@HanCardiomd) 's Twitter Profile Photo

Data Point to Better Survival With vs IABP in High-Risk

This latest propensity-adjusted analysis also linked Impella to less MI and

PROTECT IV results still lie years ahead
TCTMD TCTMD_Caitlin Mamas A. Mamas Shelley Zieroth MeiLan Han
tctmd.com/news/us-claims…

account_circle
Dr. Joss Reimer(@jossreimer) 's Twitter Profile Photo

Take home message:
We are expecting rates of to go up in the fall and winter.
Get whichever booster is available to you. (And get your flu shot while you are at it to protect yourself, your loved ones and to help decrease demand on the healthcare system)

account_circle
Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

SGLT2i therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin
👉 tafamidis-treated ATTR-CM👥, initiation of dapagliflozin was well tolerated
👉💊DAPA ⤵️NT-proBNP; ⤵️diuretics demand
📁 onlinelibrary.wiley.com/doi/10.1002/eh…

SGLT2i therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin 👉 tafamidis-treated ATTR-CM👥, initiation of dapagliflozin was well tolerated 👉💊DAPA ⤵️NT-proBNP; ⤵️diuretics demand 📁 onlinelibrary.wiley.com/doi/10.1002/eh…
account_circle
iMedicus Cardiology & Diabetes(@iMedicus_ca) 's Twitter Profile Photo

Join us for Innovations in Heart Failure Management at CCC 2022! See the initiatives colleagues from across Canada have implemented to optimize GDMT. Visit cardiocongress.ca to register. Shelley Zieroth CHFS

Join us for Innovations in Heart Failure Management at CCC 2022! See the initiatives colleagues from across Canada have implemented to optimize GDMT. Visit cardiocongress.ca to register. @ShelleyZieroth @CanHFSociety #CCC2022 #CardioTwitter #CardioEd #HeartFailure
account_circle
Thomas Hanff, MD MSCE(@TomHanffMD) 's Twitter Profile Photo

Up now JHLT

How sick are patients waiting for heart transplant with an IABP? At Status 2, they have the same priority as those with refractory VT/VF, or TAH, for example, and a higher priority than high-dose inotrope Status 3. Is this justified? 1/n
jhltonline.org/article/S1053-…

Up now @TheJHLT How sick are patients waiting for heart transplant with an IABP? At Status 2, they have the same priority as those with refractory VT/VF, or TAH, for example, and a higher priority than high-dose inotrope Status 3. Is this justified? 1/n jhltonline.org/article/S1053-…
account_circle
Robert Mentz, MD(@robmentz) 's Twitter Profile Photo

JCF is now accepting applications for our next round of the 🌟Reviewer Mentorship Program🌟

The program last yr was a huge success. Lots of learnings & tangible output including many JCF editorials!

Mentees & Mentors Apply now

Due Nov 21!!

hfsa.org/jcf-reviewer-m…

JCF is now accepting applications for our next round of the 🌟Reviewer Mentorship Program🌟 The program last yr was a huge success. Lots of learnings & tangible output including many JCF editorials! Mentees & Mentors Apply now Due Nov 21!! hfsa.org/jcf-reviewer-m…
account_circle